At this time, posts about Samsung Pharmaceutical are rapidly increasing on portals and securities communities. Today, foreigners have tentatively net purchased 130,628 shares of Samsung Pharmaceutical, and institutions have net purchased 1,000 shares. Samsung Pharmaceutical is known as a leading pharmaceutical company specializing in over-the-counter drugs such as Gas Myeongsu.
As of 1:30 PM on the 25th, Samsung Pharmaceutical's stock price is 7,090 KRW, down 5.97% from the previous day, with a trading volume of 6,782,552 shares, which is 100.61% of the 5-day average trading volume. On February 19, Samsung Pharmaceutical became a market issue with the headline "President Moon visits vaccine syringe manufacturer, causing a surge."
In addition to Samsung Pharmaceutical, posts by investors are also rapidly increasing for Hyundai Wia (011210), Signetics (033170), and Zinus (013890).

※Source: AI Investment Assistant AI Lassiro
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
